THE COMBINED IMPACT OF HLA AND NON-HLA INCOMPATIBILITY BETWEEN DONORS AND RECIPIENTS ON KIDNEY TRANSPLANT SURVIVAL: A GENOMIC ANALYSIS IN A PROSPECTIVE COHORT

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/9fe60bd452c0ee26ac72e6b78808c128.pdf
THE COMBINED IMPACT OF HLA AND NON-HLA INCOMPATIBILITY BETWEEN DONORS AND RECIPIENTS ON KIDNEY TRANSPLANT SURVIVAL: A GENOMIC ANALYSIS IN A PROSPECTIVE COHORT

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Rainer
Oberbauer
Michael Kammer michael.kammer@meduniwien.ac.at Medical University of Vienna Nephrology Vienna Austria -
Andreas Heinzel andreas.heinzel@meduniwien.ac.at Medical University of Vienna Nephroogy Vienna Austria -
Stephen Shoebridge stephen.shoebridge@meduniwien.ac.at Medical University of Vienna Nephrology Vienna Austria -
Roman Reindl-Schwaighofer roman.reindl-schwaighofer@meduniwien.ac.at Medical University of Vienna Nephrology Vienna Austria -
Karin Hu karin.hu@meduniwien.ac.at Medical University of Vienna Nephrology Vienna Austria -
Hao Shan Chen haoshan.chen@meduniwien.ac.at Medical University of Vienna Nephrology Vienna Austria -
Alexander Kainz alexander.kainz@meduniwien.ac.at Medical University of Vienna Nephrology Vienna Austria -
Isamil Daoudi ismail.daoudi@meduniwien.ac.at Medical University of Vienna Nephrology Vienna Austria -
Ana Claro David ana.clarodavid@meduniwien.ac.at Medical University of Vienna Nephrology Vienna Austria -
Gottfried Fischer gottfried.fischer@meduniwien.ac.at Medical University of Vienna HLA Lab Vienna Austria -
Brendan Keating spudwelike@gmail.com University of Pennsylvania Surgery Philadelphia United States -
Matthias Niemann matthias.niemann@pirche.com PIRCHE AG PIRCHE AG Berlin Germany -
Rainer Oberbauer rainer.oberbauer@meduniwien.ac.at Medical University of Vienna Nephrology Vienna Austria *
-
-

Kidney transplantation outcomes are strongly influenced by immunological compatibility between donor and recipient. While genetic mismatches in the Human Leucocyte Antigen (HLA) region have long been recognized as key determinants of graft survival, increasing evidence, including our own previous work, suggests that non-HLA alloimmunity also plays a critical role.

We sequenced the exomes of 1187 pairs of deceased kidney donors and recipients from a prospective cohort at the Vienna General Hospital recruited between January 1, 2012, and June 15, 2023. Non-HLA mismatch was computed by considering non-synonymous single nucleotide polymorphisms encoding for proteins in the kidney that are transmembrane proteins located in the cell membrane or secreted (nsSNP-tcmsk). Using adjusted Cox proportional hazards models, we replicated results from our earlier work in recipients with primary graft function after 90 days, and extended the analysis to the combination of nsSNP-tcmsk with Eplets mismatch to assess their associations with graft loss in the full cohort.

Of 20421 human proteins, 2371 were considered for the nsSNP-tcmsk score. In our replication analysis we estimated a hazard ratio (HR) for nsSNP-tcmsk of 1.33 (95% CI 1.02-1.74) for graft loss per increase of one interquartile range. The nsSNP-tcmsk and Eplets scores were uncorrelated (  0.04). A composite score of nsSNP-tcmsk and Eplets mismatches was associated with graft loss with a HR of 1.76 (95% CI 1.20-2.57) corresponding to an absolute difference in 7-year restricted mean survival time between the 1st and 4th quartiles of 0.52 years (95% CI 0.16-0.87 years). 

The impact of non-HLA donor-recipient mismatch on transplant loss is of the same magnitude as established mismatch scores in the HLA region. Together, these compatibility scores may be further validated as guiding markers for the required strength of maintenance immunosuppression.

Kewords